Article

Incorporating tumor genomic profiling and drug screening through circulating tumor cell- derived organoids into clinical practice for the management of Gastrointestinal Cancers

2024-04-30

Abstract excerpt

<title>Abstract</title> <p><bold>Purpose</bold> Precision medicine aims to revolutionize healthcare by tailoring treatment regimens. The study aimed to integrate comprehensive tumor genomic profiling (CTGP) by targeted-gene panel sequencing and drug screening by circulating tumor cell-derived organoids (CTOs) into clinical practice for the treatment of gastrointestinal (GI) cancers. <bold>Methods</bold> Nine pati...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5df8367d-769b-50c7-a899-76cde022cd23
DOI: 10.21203/rs.3.rs-4309557/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Incorporating tumor genomic profiling and drug screening through circulating tumor cell- derived organoids into clinical practice for the management of Gastrointestinal CancersDOI 10.21203/rs.3.rs-4309557/v1Read

Comprehensive genomic profiling for patients with chemotherapy‐naïve advanced cancerSemantic proximity Read

Clinical Utility of Genomic Profiling Tests in Patients with Advanced Gastrointestinal Cancers.Semantic proximity Read

Prognostic impact of genomically matched therapy for solid cancers using real-world data from a provincial hospital in JapanSemantic proximity Read

Health Care Impact of Comprehensive Genomic Profiling of Solid Tumors in Patient Management Using POWER (Precision Oncology at Western University).Semantic proximity Read

Integrating cfDNA Liquid Biopsy and Organoid-Based Drug Screening Reveals PI3K Signaling as a Promising Therapeutic Target in Colorectal CancerSemantic proximity Read

Clinical Significance of Multi-Cancer Genome Profiling: Data from A Japan HospitalSemantic proximity Read

First-Line Genomic Profiling in Previously Untreated Advanced Solid Tumors for Identification of Targeted Therapy Opportunities.Semantic proximity Read

Prognostic impact of cancer genomic profile testing for advanced or metastatic solid tumors in clinical practice.Semantic proximity Read

Pragmatic Nationwide Master Observational Trial Based on Genomic Alterations in Advanced Solid Tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS)-II Study Protocol KCSG AL-22-09Semantic proximity Read

Widespread adoption of precision anticancer therapies after implementation of pathologist-directed comprehensive genomic profiling across a large US health systemSemantic proximity Read

Clinical decisions by the molecular tumor board on comprehensive genomic profiling tests in Japan: A retrospective observational study.Semantic proximity Read

Genomic profiling and expanded use of targeted anticancer drugs in solid cancers with exhausted evidence-based treatment options: the PRECODE study protocolSemantic proximity Read